AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2023
May 4, 2023
30786_dirs_2023-05-04_db3169e9-4c2c-4c28-8203-0e703e889ead.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-04-26
Reporting Person: COREY COLLEEN (EVP, Global Human Resources)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 15880.000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (600) | Direct | ||
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (990) | Direct | ||
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (722) | Direct | ||
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (760) | Direct | ||
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (1388) | Direct | ||
| Non-Qualified Stock Option (right to buy) | $524.30 | 2030-09-02 | Bio-Rad A Common Stock (1444) | Direct | |
| Non-Qualified Stock Option (right to buy) | $814.95 | 2031-09-01 | Bio-Rad A Common Stock (1013) | Direct |
Footnotes
F1: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F2: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F3: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F4: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F7: The option, representing a right to purchase a total of 1,444 shares, becomes exercisable in four equal annual installments beginning on September 2, 2021, which is the first anniversary of the date on which the option was granted.
F8: The option, representing a right to purchase a total of 1,013 shares, becomes exercisable in four equal annual installments beginning on September 1, 2022, which is the first anniversary of the date on which the option was granted.